WealthShield Partners’s Twist Bioscience TWST Stock Holding History

WealthShield Partners’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-50	Closed	-$6K	–	1134
2021 Q1	$6K	Buy	+50	New	+$7.59K	﹤0.01%	940

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

WealthShield Partners's TWST Position: Q2 2021 in Review

WealthShield Partners sold out of Twist Bioscience (TWST) in Q2 2021, closing a stake of 50 shares — an estimated $6K sold.

WealthShield Partners first reported a position in TWST in Q1 2021 and held it in 1 quarter. The position peaked at $6K in Q1 2021. 244 funds tracked by Wall St. Rank hold TWST as of Q2 2021.

WealthShield Partners reported no remaining Twist Bioscience position as of Q2 2021 after selling out during the quarter.
WealthShield Partners sold 50 Twist Bioscience shares in Q2 2021, an estimated $6K.
WealthShield Partners first reported a position in Twist Bioscience in Q1 2021 and held it in 1 quarter.
WealthShield Partners's Twist Bioscience position peaked at $6K in Q1 2021.
244 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2021.

Based on WealthShield Partners's 13F filing for Q2 2021, filed 6 Aug 2021.